Medicare Procedure and Patient Information
Conditions of Medicare patients treated by Dr. Amir H. Lebastchi, MD in 2020
The most common conditions of Medicare patients that Dr. Amir H. Lebastchi, MD treated during 2020 were high cholesterol.
71 | |
Dr. Amir H. Lebastchi, MD is an urologic oncologist in Los Angeles, CA specializing in urologic oncology. Dr. Amir H. Lebastchi, MD is affiliated with Keck Medical Center of USC, USC Arcadia Hospital and USC CARE MEDICAL GROUP INC.
1441 Eastlake Avenue Suite 7416
Los Angeles, CA 90089
1516 San Pablo Street Hc3 - Suite 3500 Hc3 - Suite 3500
Los Angeles, CA 90033
1808 Verdugo Boulevard Suite 318 Suite 318
Glendale, CA 91208
25751 Mcbean Parkway Suite 200 Suite 200
Santa Clarita, CA 91355
9033 Wilshire Boulevard Suite 406 Suite 406 Beverly Hills - Urology, Suite 406
Beverly Hills, CA 90211
9500 Stockdale Highway Suite 202 Suite 202
Bakersfield, CA 93311
The most common conditions of Medicare patients that Dr. Amir H. Lebastchi, MD treated during 2020 were high cholesterol.
Hypertension | 0 |
---|---|
High Cholesterol | 71 |
Stroke | 0 |
Ischemic Heart Disease | 0 |
Depression | 0 |
Chronic Kidney Disease | 0 |
Asthma | 0 |
Osteoperosis | 0 |
Atrial Fibrilation | 0 |
Heart Failure | 0 |
Chronic Obstructive Pulmonary Disease | 0 |
Diabetes | 0 |
Dementia | 0 |
Cancer | 0 |
The top procedures that Dr. Amir H. Lebastchi, MD treated as an urologic oncologist in Los Angeles, CA during 2021 were diagnostic procedures, urologic procedures, minor procedures and minimally invasive procedures.
Volume of procedures performed by Dr. Amir H. Lebastchi, MD for Medicare patients.
diagnostic procedures | 49 |
---|---|
doctor visit | 185 |
minimally invasive procedures | 15 |
minor procedures | 16 |
urologic procedures | 48 |
Information about Medicare patients treated by Dr. Amir H. Lebastchi, MD.
Non-Hispanic White | 81 |
---|---|
Black | 0 |
Hispanic | 21 |
Asian | 0 |
Other | 0 |
Native American | 0 |
From 65 to 74 | 75 |
---|---|
From 75 to 84 | 40 |
85 and over | 0 |
Less than 65 | 0 |
The most common conditions of Medicare patients that Dr. Amir H. Lebastchi, MD treated during 2021 were hypertension, high cholesterol, ischemic heart disease and cancer.
Hypertension | 75 |
---|---|
High Cholesterol | 72 |
Stroke | 0 |
Ischemic Heart Disease | 52 |
Depression | 20 |
Chronic Kidney Disease | 33 |
Asthma | 0 |
Osteoperosis | 0 |
Atrial Fibrilation | 13 |
Heart Failure | 15 |
Chronic Obstructive Pulmonary Disease | 9 |
Diabetes | 34 |
Dementia | 0 |
Cancer | 42 |
The top procedures that Dr. Amir H. Lebastchi, MD treated as an urologic oncologist in Los Angeles, CA during 2022 were urologic procedures, diagnostic procedures, minimally invasive procedures and minor procedures.
Volume of procedures performed by Dr. Amir H. Lebastchi, MD for Medicare patients.
diagnostic procedures | 74 |
---|---|
doctor visit | 318 |
minimally invasive procedures | 67 |
minor procedures | 55 |
urologic procedures | 86 |
Information about Medicare patients treated by Dr. Amir H. Lebastchi, MD.
Non-Hispanic White | 122 |
---|---|
Black | 0 |
Hispanic | 24 |
Asian | 20 |
Other | 0 |
Native American | 0 |
From 65 to 74 | 95 |
---|---|
From 75 to 84 | 62 |
85 and over | 14 |
Less than 65 | 12 |
The most common conditions of Medicare patients that Dr. Amir H. Lebastchi, MD treated during 2022 were high cholesterol, hypertension, cancer and diabetes.
Hypertension | 75 |
---|---|
High Cholesterol | 75 |
Stroke | 7 |
Ischemic Heart Disease | 42 |
Depression | 20 |
Chronic Kidney Disease | 32 |
Asthma | 9 |
Osteoperosis | 9 |
Atrial Fibrilation | 11 |
Heart Failure | 16 |
Chronic Obstructive Pulmonary Disease | 12 |
Diabetes | 44 |
Dementia | 8 |
Cancer | 55 |
Volume of procedures performed by Dr. Amir H. Lebastchi, MD for Medicare patients.
The highest averages for the top procedures that Dr. Amir H. Lebastchi, MD treated as an urologic oncologist in Los Angeles, CA were urologic procedures, diagnostic procedures, minimally invasive procedures and minor procedures.
diagnostic procedures | 61 |
---|---|
doctor visit | 251 |
minimally invasive procedures | 41 |
minor procedures | 35 |
urologic procedures | 67 |
Information about Medicare patients treated by Dr. Amir H. Lebastchi, MD.
Black / African American | 0 |
---|---|
Asian / Pacific Islander | 2 |
Non-Hispanic White | 20 |
Native American / Alaskan Native | 0 |
Hispanic | 4 |
Other | 0 |
75 to 84 | 10 |
---|---|
85 and over | 1 |
Less than 65 | 1 |
65 to 74 | 17 |
The highest averages of the most common conditions of Medicare patients that Dr. Amir H. Lebastchi, MD treated were high cholesterol, hypertension, cancer and ischemic heart disease.
Hypertension | 15 |
---|---|
High Cholesterol | 21 |
Stroke | 0 |
Ischemic Heart Disease | 9 |
Depression | 4 |
Chronic Kidney Disease | 6 |
Asthma | 0 |
Osteoporosis | 0 |
Heart Failure | 3 |
Chronic Obstructive Pulmonary Disease | 2 |
Diabetes | 7 |
Atrial Fibrillation | 2 |
Cancer | 9 |
Dementia | 0 |
He is certified by the Urology - Board Certified and has a state license in Maryland.
Board Certification: Urology - Board Certified
Licensed In: Maryland
Dr. Amir H. Lebastchi, MD is associated with these hospitals and organizations:
Dr. Amir H. Lebastchi, MD appears to accept the following insurance providers: Humana ChoiceCare Network, Great-West Healthcare, Blue Shield of California, MultiPlan, TriWest, United Healthcare, Interplan, Aetna, Medicare, Cigna, Coventry, GEHA, Anthem, First Health, Private Healthcare Systems (PHCS), Beech Street, PacifiCare, Health Net, Brand New Day, Marian Health Services, Watchtower, Health Net Covered California, Kern Health Systems, Laundry and Dry Cleaning Workers Health & Welfare, USC Network, Take Care (GUAM), Union Roofers Health & Welfare Fund, Blue Shield Covered California, Presbyterian Intercommunity Hospital, NEXT and Health Plans of Nevada.
According to our sources, Dr. Amir H. Lebastchi, MD accepts the following insurance providers:
Dr. Amir H. Lebastchi, MD has an exceptional overall rating with an average of 4.8 out of 5 stars based on 10 ratings. We collect ratings and reviews of Dr. Amir H. Lebastchi, MD from all over the web to help you find the right in Los Angeles, CA.
These charts describe general payments received by Dr. Amir H. Lebastchi, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
EDAP TECHNOMED INC |
$160,622
$160,622 |
|||
---|---|---|---|---|
Koelis Inc. |
$21,455
TRINITY $21,455 |
|||
AngioDynamics, Inc. |
$2,377
Nanoknife $2,377 |
|||
Telix Pharmaceuticals |
$800
ILLUCCIX $800 |
|||
Teleflex LLC |
$193
Urolift $193 |
|||
Other |
$396
SPEEDICATH $25 |
Prolaris $23 |
ELIGARD $14 |
$333 |
Consulting Fee | $138,730 |
---|---|
Travel and Lodging | $40,923 |
Food and Beverage | $5,390 |
Honoraria | $800 |
Dr. Amir H. Lebastchi, MD has received 33 research payments totaling $95,861.
Dr. Amir Lebastchi specializes in urologic oncology. Areas of expertise for Dr. Lebastchi include bladder cancer, kidney cancer, and minimally invasive urologic procedures. Dr. Lebastchi is professionally affiliated with USC Arcadia Hospital.